Caption Management, LLC Gemini Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$3.3 - $6.32 $1.27 Million - $2.43 Million	-384,900 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.32 - $14.02 $122,608 - $271,988	19,400 Added 5.31%	384,900 $2.49 Million
Q1 2021 May 17, 2021	BUY	$11.32 - $18.0 $4.14 Million - $6.58 Million	365,500 New	365,500 $4.96 Million

2.44M

Ticker GMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,244,500
Market Cap $1.05B
Description
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.